Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2022

Filter by date:

Showing 1107 press releases before 2022

AstraZeneca aims to advance clinical practice in CV risk management with new data at ACC 2018
5 March 2018
MedImmune to create stand-alone company for early-stage inflammation and autoimmunity biologics
28 February 2018
Lynparza receives positive EU CHMP opinion in platinum-sensitive relapsed ovarian cancer
23 February 2018
US FDA approves Imfinzi for unresectable Stage III non-small cell lung cancer
19 February 2018
Selumetinib granted Orphan Drug Designation by the US FDA for neurofibromatosis type 1
15 February 2018
Brilinta significantly reduces CV events and coronary death beyond one year in heart attack survivors with multi-vessel disease
7 February 2018
Full-Year 2017 Results
2 February 2018
AstraZeneca reports top-line Phase III KRONOS trial results for PT010 triple combination therapy in chronic obstructive pulmonary disease
26 January 2018
AstraZeneca listed as one of the world’s top-100 most sustainable companies and recognised for its three-fold increase in renewable energy usage
23 January 2018
Lynparza receives approval in Japan for the treatment of advanced ovarian cancer
19 January 2018

<
42
43
44
45
46
47
48
111
>

All of our latest press releases and articles are available to explore